PR Newswire: Health

PR Newswire: Health http://www.prnewswire.co.uk/cgi/news/topic?id=699 Health Press releases distributed via PR Newswire. hourly 5 2005-01-01T00:00+00:00 PR Newswire Europe Ltd. Copyright © 1996-2008 PR Newswire Europe Ltd. All Rights Reserved. en-US 2009-11-07T01:57:03+00:00 PR Newswire: Health http://www.prnewswire.com/global/homepage/images/logo.gif http://www.prnewswire.co.uk/cgi/news/topic?id=699 Helix BioPharma Corp. schliesst Aufnahme von Patienten mit anogenitalen Warzen in seine Phase-II-Studie zu Topical Interferon Alpha-2b ab http://www.prnewswire.co.uk/cgi/news/release?id=271163 2009-11-07T01:52:00+0000 Nouvelle technologie de codage laser pour les récipients pharmaceutiques en verre http://www.prnewswire.co.uk/cgi/news/release?id=271147 2009-11-06T17:43:00+0000 U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat http://www.prnewswire.co.uk/cgi/news/release?id=271142 2009-11-06T17:06:00+0000 Raptor Pharmaceutical Corporation annonce la présentation de données concernant le NGX426, un nouvel analgésique oral non opioïde, lors du Congrès sur la douleur neuropathique http://www.prnewswire.co.uk/cgi/news/release?id=271139 2009-11-06T16:02:00+0000 Handen, de belangrijkste overdrachtsroute bij infectieziektes http://www.prnewswire.co.uk/cgi/news/release?id=271134 2009-11-06T14:40:00+0000 Astellas Pharma Europe gibt bekannt, dass die International Foundation for Dermatology einer der Preisträger der Changing Tomorrow 2009 Awards ist http://www.prnewswire.co.uk/cgi/news/release?id=271132 2009-11-06T14:14:00+0000 Astellas Pharma Europe anuncia a la ganadora de los Changing Tomorrow 2009 Awards http://www.prnewswire.co.uk/cgi/news/release?id=271131 2009-11-06T14:11:00+0000 Astellas Pharma Europe annonce que la Fondation internationale de dermatologie fait partie des lauréats du concours Changing Tomorrow 2009 http://www.prnewswire.co.uk/cgi/news/release?id=271130 2009-11-06T14:09:00+0000 Mouth Cancer - A Deadly Disease - On the Increase http://www.prnewswire.co.uk/cgi/news/release?id=271128 2009-11-06T13:24:00+0000 Nueva tecnología de codificación por láser para contenedores farmacéuticos de vidrio http://www.prnewswire.co.uk/cgi/news/release?id=271114 2009-11-06T10:15:00+0000 NIGHTBRA, the First Anti-Wrinkle Bra, Branded and Patented in Spain in 2000, is Now Being Imitated http://www.prnewswire.co.uk/cgi/news/release?id=271108 2009-11-06T10:00:00+0000 NIGHTBRA, der erste Antifalten-BH einer spanischen Marke und mit spanischem Patent seit dem Jahr 2000, wird bereits imitiert http://www.prnewswire.co.uk/cgi/news/release?id=271110 2009-11-06T10:00:00+0000 NIGHTBRA, le premier soutien-gorge antirides de marque et de brevet espagnol lancé en 2000, a déjà des imitateurs http://www.prnewswire.co.uk/cgi/news/release?id=271111 2009-11-06T10:00:00+0000 NIGHTBRA, el primer sujetador antiarrugas con marca y patente española desde el 2000, ya tiene imitadores http://www.prnewswire.co.uk/cgi/news/release?id=271112 2009-11-06T10:00:00+0000 Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center in Europe http://www.prnewswire.co.uk/cgi/news/release?id=271107 2009-11-06T09:56:00+0000 Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) http://www.prnewswire.co.uk/cgi/news/release?id=271098 2009-11-06T08:00:00+0000 Raptor Pharmaceutical Corporation meldet, dass Ergebnisse zu NGX426, einem neuartigen, nicht-opioiden, oralen Analgetikum, auf Neuropathieschmerzkonferenz vorgestellt werden http://www.prnewswire.co.uk/cgi/news/release?id=271084 2009-11-06T03:55:00+0000 Piani internazionali di marketing e vendita della Star Scientific per il prodotto nutraceutico CigRx(TM) in collaborazione con inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271081 2009-11-06T01:27:00+0000 Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts http://www.prnewswire.co.uk/cgi/news/release?id=271077 2009-11-05T23:08:00+0000 Star Scientific prévoit de réaliser le marketing et la vente mondiaux du nutraceutique CigRx(TM) en partenariat avec inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271068 2009-11-05T20:59:00+0000 Star Scientific plant internationale marketing en verkoop van nutraceuticum CigRx(TM) in samenwerking met inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271065 2009-11-05T20:13:00+0000 Star Scientific plant weltweite Vermarktung und Vertrieb des Nutraceuticals CigRx(TM) in Partnerschaft mit inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271064 2009-11-05T20:07:00+0000 Sirius Genomics a reçu un financement du PARI-CNRC pour le développement continu d'un diagnostic compagnon pour la sepsie http://www.prnewswire.co.uk/cgi/news/release?id=271063 2009-11-05T20:00:00+0000 Star Scientific planea el marketing y ventas mundiales de CigRx(TM) Nutraceutical en asociación con inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271058 2009-11-05T17:45:00+0000 Novel Laser Coding Technology for Pharmaceutical Glass Containers http://www.prnewswire.co.uk/cgi/news/release?id=271054 2009-11-05T16:43:00+0000 Sirius Genomics erhält für Weiterentwicklung eines Sepsis-Begleitdiagnostikums Finanzmittel aus dem NRC-IRAP-Programm http://www.prnewswire.co.uk/cgi/news/release?id=271036 2009-11-05T13:43:00+0000 Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion Diagnostic http://www.prnewswire.co.uk/cgi/news/release?id=271030 2009-11-05T12:58:00+0000 Sirius Genomics recibe fondos del NRC-IRAP para desarrollar el manual de diagnosis de sepsis http://www.prnewswire.co.uk/cgi/news/release?id=271031 2009-11-05T12:58:00+0000 A Star Scientific Planeia Comercialização e Publicitação Mundial do Nutracêutico CigRx(TM) em Parceria com a inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=271028 2009-11-05T12:45:00+0000 Breast Enlargement Day Case Operations Increase by 235 per Cent http://www.prnewswire.co.uk/cgi/news/release?id=270985 2009-11-05T07:55:00+0000 La société d'investissement privée Czura Thornton présente aujourd'hui Clearstone Central Laboratories en tant que dernier membre du groupe des sciences de la vie de Czura Thornton http://www.prnewswire.co.uk/cgi/news/release?id=270981 2009-11-05T07:00:00+0000 Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference http://www.prnewswire.co.uk/cgi/news/release?id=270963 2009-11-05T00:43:00+0000 Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health http://www.prnewswire.co.uk/cgi/news/release?id=270955 2009-11-04T19:56:00+0000 Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas http://www.prnewswire.co.uk/cgi/news/release?id=270904 2009-11-04T14:00:00+0000 Poverty and Discrimination on the Rise for Disabled People: Leonard Cheshire Disability Report http://www.prnewswire.co.uk/cgi/news/release?id=270895 2009-11-04T13:53:00+0000 Ortho Clinical Diagnostics Lance le Premier Centre De Monitoring a Distance en Europe http://www.prnewswire.co.uk/cgi/news/release?id=270894 2009-11-04T13:29:00+0000 Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center in Europe http://www.prnewswire.co.uk/cgi/news/release?id=270890 2009-11-04T13:05:00+0000 Filtrona Porous Technologies crea MediSponge(R) RBR http://www.prnewswire.co.uk/cgi/news/release?id=270879 2009-11-04T12:00:00+0000 Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings http://www.prnewswire.co.uk/cgi/news/release?id=270881 2009-11-04T12:00:00+0000 FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease http://www.prnewswire.co.uk/cgi/news/release?id=270882 2009-11-04T12:00:00+0000 Filtrona Porous Technologies met au point un produit novateur grâce à la synergie des technologies de la fibre et de la mousse : Voici le pansement pour le soin des plaies MediSponge(R) RBR http://www.prnewswire.co.uk/cgi/news/release?id=270883 2009-11-04T12:00:00+0000 Filtrona Porous Technologies führt dank Synergien in der Schaum-Faser-Technologie neue, innovative Produktentwicklung durch und stellt den Wundverband MediSponge(R) RBR vor http://www.prnewswire.co.uk/cgi/news/release?id=270884 2009-11-04T12:00:00+0000 Bounty Announces Weaning & Milk Policy Changes http://www.prnewswire.co.uk/cgi/news/release?id=270865 2009-11-04T09:00:00+0000 ThromboGenics NV - Q3 2009 Business Update http://www.prnewswire.co.uk/cgi/news/release?id=270844 2009-11-04T06:30:00+0000 Obituary: Professor James Boyer Brown http://www.prnewswire.co.uk/cgi/news/release?id=270839 2009-11-04T05:05:00+0000 Helix BioPharma Corp. gibt Ergebnisse des Geschäftsjahres 2009 bekannt http://www.prnewswire.co.uk/cgi/news/release?id=270825 2009-11-03T20:21:00+0000 DigiGait dient der Erforschung von Kinderkrankheiten http://www.prnewswire.co.uk/cgi/news/release?id=270778 2009-11-03T12:00:00+0000 MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014 http://www.prnewswire.co.uk/cgi/news/release?id=270763 2009-11-03T09:30:00+0000 Die private Investmentfirma Czura Thornton nimmt Clearstone Central Laboratories als neues Mitglied in die Unternehmensgruppe Thornton Life Science Group auf http://www.prnewswire.co.uk/cgi/news/release?id=270753 2009-11-03T08:00:00+0000 Christmas Shopping 2009: Will the British be Deterred by Swine Flu? http://www.prnewswire.co.uk/cgi/news/release?id=270746 2009-11-03T07:30:00+0000 Astellas Pharma Europe Announces the International Foundation for Dermatology a Winner of the Changing Tomorrow 2009 Awards http://www.prnewswire.co.uk/cgi/news/release?id=270739 2009-11-03T06:35:00+0000 Combined Pharma Event Visitor Numbers 5% Ahead of 2008 Frankfurt Record http://www.prnewswire.co.uk/cgi/news/release?id=270725 2009-11-02T22:18:00+0000 AMD LASERS erhält ISO-13485-Zertifizierung http://www.prnewswire.co.uk/cgi/news/release?id=270709 2009-11-02T18:03:00+0000 Master of Malt Launches 'Whisky 4 Movember' - a Secret, Charity Bottling http://www.prnewswire.co.uk/cgi/news/release?id=270705 2009-11-02T17:15:00+0000 CeloNova est la première société à produire des microsphères emboliques de très grande taille http://www.prnewswire.co.uk/cgi/news/release?id=270691 2009-11-02T16:15:00+0000 AMD LASERS obtient la certification ISO 13485 http://www.prnewswire.co.uk/cgi/news/release?id=270689 2009-11-02T15:49:00+0000 Abbott's XIENCE PRIME(TM) and XIENCE V(R) Receive Indications in Europe for Treatment of Patients with Diabetes http://www.prnewswire.co.uk/cgi/news/release?id=270679 2009-11-02T14:51:00+0000 Bicycle Therapeutics et Pepscan concluent un partenariat pour l'utilisation de la technologie peptidique restreinte dans la mise au point de nouveaux produits biothérapeutiques http://www.prnewswire.co.uk/cgi/news/release?id=270662 2009-11-02T14:00:00+0000 Bicycle Therapeutics und Pepscan gehen Partnerschaft zur Nutzung der Constrained-Peptid-Technologie für die Entwicklung neuartiger Biotherapeutika ein http://www.prnewswire.co.uk/cgi/news/release?id=270663 2009-11-02T14:00:00+0000 Bicycle Therapeutics y Pepscan se asocian http://www.prnewswire.co.uk/cgi/news/release?id=270664 2009-11-02T14:00:00+0000 Bicycle Therapeutics and Pepscan Enter Into Partnership to Apply Constrained Peptide Technology in the Development of Novel Biotherapeutics http://www.prnewswire.co.uk/cgi/news/release?id=270669 2009-11-02T14:00:00+0000 CeloNova stellt als erstes Unternehmen besonders grosse Mikrokugeln zur Embolisierung her http://www.prnewswire.co.uk/cgi/news/release?id=270659 2009-11-02T13:58:00+0000 Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group http://www.prnewswire.co.uk/cgi/news/release?id=270656 2009-11-02T13:15:00+0000 AMD LASERS consigue el certificado ISO 13485 http://www.prnewswire.co.uk/cgi/news/release?id=270650 2009-11-02T13:00:00+0000 AMD LASERS Obtains Certification in ISO 13485 http://www.prnewswire.co.uk/cgi/news/release?id=270654 2009-11-02T13:00:00+0000 Media Advisory - Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009 http://www.prnewswire.co.uk/cgi/news/release?id=270644 2009-11-02T12:30:00+0000 Avis aux médias - Oncolytics Biotech(R) Inc. fera une présentation à BIO-Europe 2009 http://www.prnewswire.co.uk/cgi/news/release?id=270645 2009-11-02T12:30:00+0000 Pressemitteilung - Oncolytics Biotech(R) Inc. wird auf der BIO-Europe 2009 vertreten sein http://www.prnewswire.co.uk/cgi/news/release?id=270646 2009-11-02T12:30:00+0000 Correction: The Advisory Council on the Misuse of Drugs and the Royal Pharmaceutical Society http://www.prnewswire.co.uk/cgi/news/release?id=270642 2009-11-02T12:21:00+0000 New Shire Board Member http://www.prnewswire.co.uk/cgi/news/release?id=270618 2009-11-02T10:23:00+0000 Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc. http://www.prnewswire.co.uk/cgi/news/release?id=270615 2009-11-02T09:49:00+0000 InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways http://www.prnewswire.co.uk/cgi/news/release?id=270598 2009-11-02T08:00:00+0000 Französische Mediziner planen die Durchführung einer Studie zum Koronarstentsystem CATANIA(TM) mit 2000 Patienten http://www.prnewswire.co.uk/cgi/news/release?id=270569 2009-11-02T03:00:00+0000 Des médecins français mènent une étude portant sur l'endoprothèse coronarienne CATANIA(TM) auprès de 2000 patients http://www.prnewswire.co.uk/cgi/news/release?id=270568 2009-11-02T02:45:00+0000 Médicos franceses llevarán a cabo el estudio de 2.000 pacientes del stent coronario CATANIA(TM) http://www.prnewswire.co.uk/cgi/news/release?id=270558 2009-10-31T12:47:00+0000 CeloNova es la primera compañía en producir microesferas embólicas de gran tamaño http://www.prnewswire.co.uk/cgi/news/release?id=270557 2009-10-31T12:23:00+0000 Cambodia: World AIDS Day HIV Campaign, 'Testing Millions,' to Again Launch During Cambodia's National Water Festival http://www.prnewswire.co.uk/cgi/news/release?id=270556 2009-10-31T08:00:00+0000 /C O R R E C T I O N -- CeloNova BioSciences, Inc./ http://www.prnewswire.co.uk/cgi/news/release?id=270553 2009-10-31T00:55:00+0000 Les Asklepios Clinics Hamburg collaborent avec la société internationale de soins de santé de premier plan Bupa International http://www.prnewswire.co.uk/cgi/news/release?id=270548 2009-10-31T00:00:00+0000 CeloNova First to Produce Super-Sized Embolic Microsphere http://www.prnewswire.co.uk/cgi/news/release?id=270545 2009-10-30T23:18:00+0000 Warner Chilcott finalise l'acquisition de la division mondiale de produits pharmaceutiques sur ordonnance de marque de P&G http://www.prnewswire.co.uk/cgi/news/release?id=270544 2009-10-30T22:31:00+0000 Warner Chilcott schliesst Übernahme des globalen Geschäftsbereichs verschreibungspflichtiger Markenprodukte von P&G ab http://www.prnewswire.co.uk/cgi/news/release?id=270543 2009-10-30T22:28:00+0000 Warner Chilcott completa la adquisición de los negocios farmacéuticos de marca mundial P&G http://www.prnewswire.co.uk/cgi/news/release?id=270540 2009-10-30T20:47:00+0000 Vertreter der US-Gesundheitsbehörde FDA referieren auf Medizintechnik-Workshop der RAPS in Brüssel http://www.prnewswire.co.uk/cgi/news/release?id=270535 2009-10-30T20:02:00+0000 Asklepios Clinics Hamburg coopera con la compañía de asistencia médica líder internacional Bupa International http://www.prnewswire.co.uk/cgi/news/release?id=270531 2009-10-30T19:53:00+0000 French Physicians to Conduct 2000-Patient Study of CATANIA(TM) Coronary Stent http://www.prnewswire.co.uk/cgi/news/release?id=270528 2009-10-30T18:55:00+0000 Des représentants de la FDA prendront la parole à l'atelier sur les dispositifs médicaux organisé par la RAPS à Bruxelles http://www.prnewswire.co.uk/cgi/news/release?id=270526 2009-10-30T18:43:00+0000 CCBR-SYNARC amplía las capacidades de captura de datos electrónicos http://www.prnewswire.co.uk/cgi/news/release?id=270525 2009-10-30T18:40:00+0000 CCBR-SYNARC renforce ses capacités de capture de données électroniques http://www.prnewswire.co.uk/cgi/news/release?id=270521 2009-10-30T18:20:00+0000 CCBR-SYNARC weitert Möglichkeiten zur elektronischen Datenerfassung aus http://www.prnewswire.co.uk/cgi/news/release?id=270520 2009-10-30T18:14:00+0000 London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference http://www.prnewswire.co.uk/cgi/news/release?id=270496 2009-10-30T15:23:00+0000 Asklepios Clinics Hamburg Cooperate With the Internationally Leading Healthcare Company Bupa International http://www.prnewswire.co.uk/cgi/news/release?id=270494 2009-10-30T15:20:00+0000 Les experts de PRA International présenteront lors d'une séance à l'occasion de la 8e édition des Annual Partnerships in Clinical Trials 2009 http://www.prnewswire.co.uk/cgi/news/release?id=270485 2009-10-30T14:07:00+0000 Experten von PRA International präsentieren Sitzung bei der 8. Annual Partnerships in Clinical Trials 2009 http://www.prnewswire.co.uk/cgi/news/release?id=270484 2009-10-30T14:01:00+0000 Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business http://www.prnewswire.co.uk/cgi/news/release?id=270482 2009-10-30T13:20:00+0000 Shire Continues to Deliver Excellent Growth From Core Products http://www.prnewswire.co.uk/cgi/news/release?id=270479 2009-10-30T13:08:00+0000 PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 http://www.prnewswire.co.uk/cgi/news/release?id=270469 2009-10-30T12:30:00+0000 Los expertos de PRA International estarán en la sesión de la 8 Asociación Anual Clinical Trials 2009 http://www.prnewswire.co.uk/cgi/news/release?id=270471 2009-10-30T12:30:00+0000 CCBR-SYNARC Expands Electronic Data Capture Capabilities http://www.prnewswire.co.uk/cgi/news/release?id=270462 2009-10-30T12:00:00+0000 Global Phase III Study Results Show Eribulin Meets Primary Endpoint Of Overall Survival http://www.prnewswire.co.uk/cgi/news/release?id=270444 2009-10-30T08:30:00+0000 U.S. FDA Officials to Speak at RAPS Medical Device Workshop in Brussels http://www.prnewswire.co.uk/cgi/news/release?id=270441 2009-10-30T08:00:00+0000 Helix BioPharma Corp. Announces Fiscal 2009 Results http://www.prnewswire.co.uk/cgi/news/release?id=270428 2009-10-30T01:48:00+0000 Octapharma-Gruppe und Fresenius Kabi gehen exklusives Lizenz-, Entwicklungs- und Vertriebsabkommen für HESyliertes rekombinantes Protein ein http://www.prnewswire.co.uk/cgi/news/release?id=270408 2009-10-29T19:33:00+0000 Octapharma Group en Fresenius Kabi ondertekenen Exclusieve Vergunnings-, Ontwikkelings- en Leveringsovereenkomst voor met HES gemodificeerde Recombinante Proteïne. http://www.prnewswire.co.uk/cgi/news/release?id=270405 2009-10-29T18:48:00+0000 Octapharma Group e Fresenius Kabi stipulano un contratto esclusivo di licenza, sviluppo e fornitura per una proteina ricombinante HESilata http://www.prnewswire.co.uk/cgi/news/release?id=270403 2009-10-29T18:41:00+0000 Octapharma Group y Fresenius Kabi llegan a un acuerdo de licencia, desarrollo y suministro en exclusiva http://www.prnewswire.co.uk/cgi/news/release?id=270401 2009-10-29T18:34:00+0000 Octapharma Group et Fresenius Kabi signent une licence exclusive d'accord de développement et d'approvisionnement pour une protéine recombinante à HES http://www.prnewswire.co.uk/cgi/news/release?id=270400 2009-10-29T18:29:00+0000 Octapharma Group e Fresenius Kabi Entram em Acordo Exclusivo de Licenciamento, Desenvolvimento e Fornecimento para uma Proteína Recombinante HESylated http://www.prnewswire.co.uk/cgi/news/release?id=270393 2009-10-29T18:02:00+0000 ADVANCE bietet neue Erkenntnisse im Kampf gegen schwere Diabetes-Komplikationen http://www.prnewswire.co.uk/cgi/news/release?id=270361 2009-10-29T15:07:00+0000 O estudo ADVANCE revela novos critérios na luta contra as complicações graves da diabetes http://www.prnewswire.co.uk/cgi/news/release?id=270347 2009-10-29T13:44:00+0000 CHEENY KUM: The Mobile - Online Way to Monitor Diabetes http://www.prnewswire.co.uk/cgi/news/release?id=270342 2009-10-29T13:13:00+0000 Whitepaper From Mirial Explains how Visual Communication Technology can Improve Healthcare Services http://www.prnewswire.co.uk/cgi/news/release?id=270337 2009-10-29T12:58:00+0000 Further Expansion for Movianto in the Benelux Region http://www.prnewswire.co.uk/cgi/news/release?id=270320 2009-10-29T11:57:00+0000 "My Beautiful Face" - The Next Chapter http://www.prnewswire.co.uk/cgi/news/release?id=270315 2009-10-29T10:24:00+0000 Cosmetic Surgery Boom in Women Over 50 http://www.prnewswire.co.uk/cgi/news/release?id=270292 2009-10-29T07:00:00+0000 Pragmedic Implements World-Class Healthcare Solution for Emaar Healthcare http://www.prnewswire.co.uk/cgi/news/release?id=270280 2009-10-29T06:30:00+0000 AMT Starts Development LPLChip(TM) With Progenika http://www.prnewswire.co.uk/cgi/news/release?id=270276 2009-10-29T06:00:00+0000 Shire vient d'obtenir un accord d'extension européen pour l'indication du FOSRENOL(R) dans le traitement des insuffisances rénales chroniques http://www.prnewswire.co.uk/cgi/news/release?id=270268 2009-10-28T22:12:00+0000 Roche lance un nouvel instrument de type cobas p 630 et le logiciel AMPLILINK version 3.3 avec la marque CE http://www.prnewswire.co.uk/cgi/news/release?id=270262 2009-10-28T19:49:00+0000 Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein http://www.prnewswire.co.uk/cgi/news/release?id=270257 2009-10-28T18:24:00+0000 Roche presenta el nuevo instrumento cobas p 630 y el software de la serie AMPLILINK 3.3 con Marca CE http://www.prnewswire.co.uk/cgi/news/release?id=270253 2009-10-28T17:54:00+0000 Roche führt neues cobas p 630-Instrument und AMPLILINK 3.3 Serie-Software mit CE-Kennzeichnung ein http://www.prnewswire.co.uk/cgi/news/release?id=270252 2009-10-28T17:51:00+0000 Shire sichert sich erweiterte Zulassung für FOSRENOL(R) bei chronischer Nierenkrankheit http://www.prnewswire.co.uk/cgi/news/release?id=270251 2009-10-28T17:42:00+0000 Shire asegura la ampliación de la etiqueta para Europa de FOSRENOL(R) en el fallo renal crónico http://www.prnewswire.co.uk/cgi/news/release?id=270235 2009-10-28T15:39:00+0000 Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease http://www.prnewswire.co.uk/cgi/news/release?id=270160 2009-10-28T08:00:00+0000 The Countdown to Christmas - The realbuzz.com Guide to a Healthier You! http://www.prnewswire.co.uk/cgi/news/release?id=270153 2009-10-28T07:30:00+0000 Roche Introduces New cobas p 630 Instrument and AMPLILINK 3.3 Series Software With CE Mark http://www.prnewswire.co.uk/cgi/news/release?id=270146 2009-10-28T07:00:00+0000 ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402) http://www.prnewswire.co.uk/cgi/news/release?id=270139 2009-10-28T06:30:00+0000 BornFree Baby Bottles Borne Into Britain http://www.prnewswire.co.uk/cgi/news/release?id=270131 2009-10-28T06:00:00+0000 Simbionix stellt Bronchoskopie-Training der nächsten Generation vor http://www.prnewswire.co.uk/cgi/news/release?id=270121 2009-10-27T23:01:00+0000 Simbionix présente une solution de nouvelle génération pour la formation en bronchoscopie http://www.prnewswire.co.uk/cgi/news/release?id=270119 2009-10-27T23:00:00+0000 Raptor Pharmaceutical Corp. präsentiert auf dem 8. jährlichen BIO Investor Forum http://www.prnewswire.co.uk/cgi/news/release?id=270117 2009-10-27T22:22:00+0000 Raptor Pharmaceutical Corp. effectuera une présentation lors du 8e forum annuel BIO des investisseurs http://www.prnewswire.co.uk/cgi/news/release?id=270116 2009-10-27T21:58:00+0000 eBioscience neemt Bender MedSystems over; overname resulteert in verwerving van hypermoderne productlijnen en uitbreiding van internationale activiteiten http://www.prnewswire.co.uk/cgi/news/release?id=270102 2009-10-27T19:36:00+0000 Jordan Unveils State of the Art Healthcare Technology in Hospital Trial http://www.prnewswire.co.uk/cgi/news/release?id=270087 2009-10-27T18:31:00+0000 eBioscience übernimmt Bender MedSystems; mit der Zusammenführung der beiden Unternehmen werden die erstklassigen Produktreihen und die Geschäftstätigkeit auf internationaler Ebene weiter ausgebaut http://www.prnewswire.co.uk/cgi/news/release?id=270083 2009-10-27T17:48:00+0000 eBioscience fait l'acquisition de Bender MedSystems ; le regroupement des entreprises permet d'ajouter des gammes de produits de pointe et d'accroître les opérations internationales http://www.prnewswire.co.uk/cgi/news/release?id=270082 2009-10-27T17:42:00+0000 Masimo(R) inaugure son centre d'exploitation international en Suisse http://www.prnewswire.co.uk/cgi/news/release?id=270072 2009-10-27T16:15:00+0000 Masimo(R) eröffnet ein internationales Betriebszentrum in der Schweiz http://www.prnewswire.co.uk/cgi/news/release?id=270073 2009-10-27T16:15:00+0000 Kwik-Fit Insurance Staff "Rock the Boat" for Kidney Research http://www.prnewswire.co.uk/cgi/news/release?id=270071 2009-10-27T16:02:00+0000 eBioscience acquisisce Bender MedSystems; il connubio tra le due aziende garantisce linee di prodotto all'avanguardia e l'espansione delle attività in ambito internazionale http://www.prnewswire.co.uk/cgi/news/release?id=270055 2009-10-27T14:14:00+0000 Simbionix Introduces the Next Generation in Bronchoscopy Training http://www.prnewswire.co.uk/cgi/news/release?id=270050 2009-10-27T13:55:00+0000 eBioscience adquiere Bender MedSystems http://www.prnewswire.co.uk/cgi/news/release?id=270049 2009-10-27T13:50:00+0000 ADVANCE rivela nuovi importanti risultati nella lotta contro le complicazioni gravi del diabete http://www.prnewswire.co.uk/cgi/news/release?id=270047 2009-10-27T13:26:00+0000 eBioscience Adquire Bender MedSystems; A Combinação Entre Empresas Acrescenta Linhas de Produto de Vanguarda e Expande as Actividades Internacionais http://www.prnewswire.co.uk/cgi/news/release?id=270023 2009-10-27T12:04:00+0000 Raptor Pharmaceutical Corp. to Present at the 8th Annual BIO Investor Forum http://www.prnewswire.co.uk/cgi/news/release?id=270012 2009-10-27T11:00:00+0000 Promise of Multiple Benefits Underlines the Growing Popularity of Lab-on-chip and Microfluidics, Says Frost & Sullivan http://www.prnewswire.co.uk/cgi/news/release?id=270005 2009-10-27T10:00:00+0000 Los alimentos médicos reducen el uso de medicamentos anticonvulsivos http://www.prnewswire.co.uk/cgi/news/release?id=269957 2009-10-27T06:00:00+0000 Les aliments fonctionnels réduisent les coûts médicaux et l'usage de médicaments anticonvulsivants lors du traitement d'une neuropathie diabétique, selon l'étude de HealthCore présentée à l'occasion de l'ISPOR http://www.prnewswire.co.uk/cgi/news/release?id=269959 2009-10-27T06:00:00+0000 Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR http://www.prnewswire.co.uk/cgi/news/release?id=269960 2009-10-27T06:00:00+0000 Laut einer auf der ISPOR vorgestellten HealthCore-Studie reduziert medizinische Nahrung sowohl die medizinischen Kosten als auch den Einsatz krampflösender Mittel bei der Behandlung von diabetischer Neuropathie http://www.prnewswire.co.uk/cgi/news/release?id=269961 2009-10-27T06:00:00+0000 eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations http://www.prnewswire.co.uk/cgi/news/release?id=269941 2009-10-27T00:00:00+0000 Hospira voltooit gedecentraliseerde procedure voor generisch Docetaxel - volledige lancering verwacht eind 2010 http://www.prnewswire.co.uk/cgi/news/release?id=269933 2009-10-26T19:55:00+0000 Hospira schliesst dezentrales Zulassungsverfahren für das generische Docetaxel ab - die volle Markteinführung wird bis Ende 2010 erwartet http://www.prnewswire.co.uk/cgi/news/release?id=269931 2009-10-26T19:26:00+0000 Hospira finalise la procédure décentralisée pour le docetaxel générique - le lancement complet est prévu d'ici fin 2010 http://www.prnewswire.co.uk/cgi/news/release?id=269930 2009-10-26T19:21:00+0000 Hospira completa la procedura decentralizzata per il docetaxel generico: il lancio completo è previsto per la fine del 2010 http://www.prnewswire.co.uk/cgi/news/release?id=269928 2009-10-26T19:16:00+0000 PRA International hält Audiokonferenz ab: http://www.prnewswire.co.uk/cgi/news/release?id=269921 2009-10-26T18:41:00+0000 PRA International donnera une conférence audio : http://www.prnewswire.co.uk/cgi/news/release?id=269903 2009-10-26T16:48:00+0000 Reconnaissance de PRA International lors des prix d'excellence clinique http://www.prnewswire.co.uk/cgi/news/release?id=269902 2009-10-26T16:47:00+0000 Video: un'iniezione di terapia genica e i bambini affetti da cecità congenita ora possono vedere http://www.prnewswire.co.uk/cgi/news/release?id=269900 2009-10-26T16:13:00+0000 PRA International im Rahmen der Clinical Excellence Awards-Veranstaltung gewürdigt http://www.prnewswire.co.uk/cgi/news/release?id=269893 2009-10-26T15:20:00+0000 Vidéo : Une injection de thérapie génique suffit pour redonner la vue à des enfants souffrant de cécité congénitale http://www.prnewswire.co.uk/cgi/news/release?id=269884 2009-10-26T14:15:00+0000 Hospira Completa Procedimento Descentralizado para Medicamento Genérico Docetaxel - Lançamento Total Previsto para o Final de 2010 http://www.prnewswire.co.uk/cgi/news/release?id=269883 2009-10-26T14:07:00+0000 Hospira finaliza el procedimiento de descentralización para docetaxel genérico http://www.prnewswire.co.uk/cgi/news/release?id=269881 2009-10-26T14:04:00+0000 Ingenuity Systems verbessert den Arbeitsablauf für die experimentelle Transkriptom-Analyse einzelner Zellen http://www.prnewswire.co.uk/cgi/news/release?id=269882 2009-10-26T14:04:00+0000 Ingenuity Systems améliore son flux de travail pour l'analyse expérimentale de transcriptome dans des cellules isolées http://www.prnewswire.co.uk/cgi/news/release?id=269880 2009-10-26T14:00:00+0000 Hospira Completes Decentralised Procedure for Generic Docetaxel - Full Launch Expected By End of 2010 http://www.prnewswire.co.uk/cgi/news/release?id=269879 2009-10-26T13:56:00+0000 Health Robotics Announces Official i.v.STATION(TM) Inauguration at Gregorio Maranon University Hospital http://www.prnewswire.co.uk/cgi/news/release?id=269873 2009-10-26T13:00:00+0000 PRA International Recognized at Clinical Excellence Awards http://www.prnewswire.co.uk/cgi/news/release?id=269854 2009-10-26T12:30:00+0000 PRA International acogerá una audioconferencia: http://www.prnewswire.co.uk/cgi/news/release?id=269855 2009-10-26T12:30:00+0000 PRA International to Host Audio Conference: http://www.prnewswire.co.uk/cgi/news/release?id=269858 2009-10-26T12:30:00+0000 PRA International obtuvo el reconocimiento en los Clinical Excellence Awards http://www.prnewswire.co.uk/cgi/news/release?id=269859 2009-10-26T12:30:00+0000 Novel Cardio-Pulmonary Support Device LIFEBRIDGE(R) From Germany Gains FDA Clearance http://www.prnewswire.co.uk/cgi/news/release?id=269847 2009-10-26T11:12:00+0000 Ingenuity Systems Enhances Workflow for Experimental Transcriptome Analysis in Single Cells http://www.prnewswire.co.uk/cgi/news/release?id=269832 2009-10-26T10:00:00+0000 Ingenuity Systems mejora el flujo de trabajo para el análisis experimental de transcriptoma en células sencillas http://www.prnewswire.co.uk/cgi/news/release?id=269833 2009-10-26T10:00:00+0000 Largest British Fund for Biomedical Research Finances Project on Breakbone Fever in Leuven (K.U.Leuven) http://www.prnewswire.co.uk/cgi/news/release?id=269815 2009-10-26T09:00:00+0000 Pharmalink AB Receives Patent for Nefecon(R) Principle http://www.prnewswire.co.uk/cgi/news/release?id=269802 2009-10-26T08:00:00+0000 FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity http://www.prnewswire.co.uk/cgi/news/release?id=269793 2009-10-26T07:00:00+0000 Novo Nordisk erhält für die NovoTwist(TM)-Injektionsnadel den Design Award http://www.prnewswire.co.uk/cgi/news/release?id=269751 2009-10-26T00:01:00+0000 Novo Nordisk consigue el premio Design Award gracias a la aguja NovoTwist(TM) http://www.prnewswire.co.uk/cgi/news/release?id=269752 2009-10-26T00:01:00+0000 Novo Nordisk Wins Design Award for NovoTwist(TM) Needle http://www.prnewswire.co.uk/cgi/news/release?id=269753 2009-10-26T00:01:00+0000 Novo Nordisk remporte le prix de la conception avec l'aiguille NovoTwist(TM) http://www.prnewswire.co.uk/cgi/news/release?id=269754 2009-10-26T00:01:00+0000 Video: One Shot of Gene Therapy and Children with Congenital Blindness Can Now See http://www.prnewswire.co.uk/cgi/news/release?id=269738 2009-10-24T18:00:00+0000 Cohera Medical, Inc. recibe el permiso para probar TissuGlu(R) en seres humanos http://www.prnewswire.co.uk/cgi/news/release?id=269729 2009-10-23T21:38:00+0000 Torchmark Corporation Raises Dividend http://www.prnewswire.co.uk/cgi/news/release?id=269728 2009-10-23T21:20:00+0000 Cohera Medical, Inc. reçoit l'autorisation de commencer des essais cliniques de TissuGlu(R) en Europe http://www.prnewswire.co.uk/cgi/news/release?id=269726 2009-10-23T20:00:00+0000 Cohera Medical, Inc. erhält in Europa die Freigabe für den Beginn klinischer Studien am Menschen mit TissuGlu(R) http://www.prnewswire.co.uk/cgi/news/release?id=269725 2009-10-23T19:57:00+0000 Potentia Pharmaceuticals schliesst Lizenzierungs- und Kaufoptionsvereinbarungen mit Alcon ab http://www.prnewswire.co.uk/cgi/news/release?id=269719 2009-10-23T18:15:00+0000 Potentia Pharmaceuticals entra en acuerdos de licencia y opción de compra con Alcon http://www.prnewswire.co.uk/cgi/news/release?id=269718 2009-10-23T18:11:00+0000 Potentia Pharmaceuticals conclut des accords d'octroi de licence et d'option d'achat avec Alcon http://www.prnewswire.co.uk/cgi/news/release?id=269717 2009-10-23T17:44:00+0000 Joseph F. Finn, Jr., cesionario para el beneficio de los acreedores de EPIX Pharmaceuticals, Inc. http://www.prnewswire.co.uk/cgi/news/release?id=269687 2009-10-23T10:54:00+0000 Cohera Medical, Inc. Receives Approval To Begin Human Clinical Trials of TissuGlu(R) in Europe http://www.prnewswire.co.uk/cgi/news/release?id=269685 2009-10-23T10:53:00+0000 Joseph F. Finn, Jr., Bevollmächtigter der Gläubiger von EPIX Pharmaceuticals, Inc., veröffentlicht Erklärung zum Insolvenzverfahren http://www.prnewswire.co.uk/cgi/news/release?id=269684 2009-10-23T10:43:00+0000 "There is no Single European way to Consume Alcoholic Beverages" http://www.prnewswire.co.uk/cgi/news/release?id=269673 2009-10-23T08:58:00+0000 Research Into Cancer During Pregnancy: Treating Pregnant Women With Chemotherapy has no Detrimental Effect on the Foetus http://www.prnewswire.co.uk/cgi/news/release?id=269663 2009-10-23T07:00:00+0000 Joseph F. Finn, Jr., cessionnaire au profit des créanciers d'EPIX Pharmaceuticals, Inc., présente une déclaration au sujet du processus de liquidation http://www.prnewswire.co.uk/cgi/news/release?id=269646 2009-10-23T01:38:00+0000 Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation Process http://www.prnewswire.co.uk/cgi/news/release?id=269633 2009-10-22T19:39:00+0000 Systagenix Unveils SILVERCEL* Non-Adherent Silver Hydro Alginate Dressing http://www.prnewswire.co.uk/cgi/news/release?id=269626 2009-10-22T18:20:00+0000 MAQUET Cardiovascular reçoit l'autorisation de marquage CE pour MEGA(TM), le premier cathéter à ballonnet intra-aortique du monde de 8 Frenchs et 50 cc http://www.prnewswire.co.uk/cgi/news/release?id=269625 2009-10-22T18:16:00+0000 Helsinn annonce la fin des travaux de son nouveau centre de stabilisation situé sur son site de fabrication de médicaments en Irlande http://www.prnewswire.co.uk/cgi/news/release?id=269613 2009-10-22T15:28:00+0000 Search Recent Search PR Newswire's archived press releases from the last three working days. SEARCH http://199.230.26.105/fulltext